Page 6 - Read Online

Metabolism and Target Organ Damage

C O NT E NT S

Topic: The Evolving Nomenclature of the Metabolic Fatty Liver Syndromes:

NAFLD/NASH and MAFLD/MASLD

Review

1 From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction
Stefano Ciardullo, Gianluca Perseghin

2 Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy
response
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos-Molina

3 From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management
Paula Iruzubieta, Carolina Jimenez-Gonzalez, Joaquín Cabezas, Javier Crespo

4 Dual etiology vs. MetALD: how MAFLD and MASLD address liver diseases coexistence
Shadi Zerehpooshnesfchi, Amedeo Lonardo, Jian-Gao Fan, Reda Elwakil, Tawesak Tanwandee, Munira Y. ltarrah,
Necati Örmeci, Mohammed Eslam

Commentary

5 Metabolism, sex, and what lies beyond the scalpel in MASLD
Zong-Long Li, Yue Tang, De-Long Qin, Jia-Lu Chen, Zhao-Hui Tang
Editorial

6 MASLD or MAFLD: fatty liver by any name will pose the same challenge
Anil Chandra Anand, Dibyalochan Praharaj
Perspective

7 MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding
metabolic syndrome?
Christopher D. Byrne, Giovanni Targher

8 Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?
Yasser Fouad, Mohamed Alboraie, Ahmed Gomaa, Ming-Hua Zheng, Amedeo Lonardo

9 NAFLD to MAFLD: collaboration, not confusion - rethinking the naming of fatty liver disease
Madhususdana Girija Sanal, Robert G. Gish, Nahúm Méndez-Sánchez, Ming-Lung Yu, Wah-Kheong Chan, Lai
Wei, Henning Grønbæk, Minghua Zheng, Jacob George

10 Fatty liver disease in the pediatric population: history, definitions, and challenges in nomenclature (NAFLD/
MAFLD/MASLD)
Raúl Gómez-Mendoza, Fabiola Sánchez-Hernández, Francisco Javier Valentin-Cortez, Norberto Chávez-Tapia
Metabolism and Target Organ Damage III